| 0.3 |
1.0 |
GO:1903587 |
regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
| 0.1 |
1.2 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.1 |
0.7 |
GO:0002158 |
osteoclast proliferation(GO:0002158) |
| 0.1 |
0.3 |
GO:0035880 |
embryonic nail plate morphogenesis(GO:0035880) |
| 0.1 |
0.3 |
GO:0097623 |
potassium ion export across plasma membrane(GO:0097623) |
| 0.1 |
0.2 |
GO:0097296 |
activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
| 0.1 |
0.2 |
GO:0090298 |
negative regulation of mitochondrial DNA replication(GO:0090298) |
| 0.1 |
0.2 |
GO:0048211 |
Golgi vesicle docking(GO:0048211) |
| 0.1 |
0.2 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) negative regulation of dopaminergic neuron differentiation(GO:1904339) regulation of cardiac cell fate specification(GO:2000043) |
| 0.1 |
0.3 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.1 |
0.3 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 0.1 |
0.4 |
GO:0070100 |
negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
| 0.1 |
0.2 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.1 |
1.3 |
GO:0002076 |
osteoblast development(GO:0002076) |
| 0.1 |
0.2 |
GO:0070172 |
positive regulation of tooth mineralization(GO:0070172) |
| 0.1 |
0.2 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) thrombopoietin-mediated signaling pathway(GO:0038163) positive regulation of male germ cell proliferation(GO:2000256) |
| 0.0 |
0.2 |
GO:0003430 |
growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.0 |
0.6 |
GO:0035721 |
intraciliary retrograde transport(GO:0035721) |
| 0.0 |
0.2 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.0 |
0.2 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.0 |
0.1 |
GO:0016259 |
selenocysteine metabolic process(GO:0016259) |
| 0.0 |
0.3 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.0 |
0.2 |
GO:0097475 |
motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
| 0.0 |
0.1 |
GO:0032696 |
negative regulation of interleukin-13 production(GO:0032696) negative regulation of interleukin-10 secretion(GO:2001180) |
| 0.0 |
0.2 |
GO:0007197 |
adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.0 |
0.1 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 0.0 |
0.2 |
GO:0032693 |
negative regulation of interleukin-10 production(GO:0032693) |
| 0.0 |
0.1 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.0 |
0.1 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
| 0.0 |
0.2 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.0 |
0.1 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.0 |
0.3 |
GO:0010748 |
negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.0 |
0.1 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
| 0.0 |
0.2 |
GO:0006344 |
maintenance of chromatin silencing(GO:0006344) |
| 0.0 |
0.2 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.0 |
0.0 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.0 |
0.2 |
GO:0043312 |
neutrophil degranulation(GO:0043312) |
| 0.0 |
0.4 |
GO:0045672 |
positive regulation of osteoclast differentiation(GO:0045672) |
| 0.0 |
0.1 |
GO:0090164 |
asymmetric Golgi ribbon formation(GO:0090164) |
| 0.0 |
0.1 |
GO:2000612 |
positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072304) negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072305) mesenchymal cell apoptotic process involved in metanephros development(GO:1900200) apoptotic process involved in metanephric collecting duct development(GO:1900204) apoptotic process involved in metanephric nephron tubule development(GO:1900205) regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900211) negative regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900212) regulation of apoptotic process involved in metanephric collecting duct development(GO:1900214) negative regulation of apoptotic process involved in metanephric collecting duct development(GO:1900215) regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900217) negative regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900218) mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:1901147) regulation of metanephric DCT cell differentiation(GO:2000592) positive regulation of metanephric DCT cell differentiation(GO:2000594) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
| 0.0 |
0.2 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.0 |
0.2 |
GO:0048711 |
positive regulation of astrocyte differentiation(GO:0048711) |
| 0.0 |
0.1 |
GO:0071475 |
cellular hyperosmotic salinity response(GO:0071475) |
| 0.0 |
0.1 |
GO:0048703 |
protein sulfation(GO:0006477) embryonic neurocranium morphogenesis(GO:0048702) embryonic viscerocranium morphogenesis(GO:0048703) |
| 0.0 |
0.2 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.0 |
0.2 |
GO:0036120 |
cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.0 |
0.2 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.0 |
0.2 |
GO:0038166 |
angiotensin-activated signaling pathway(GO:0038166) |
| 0.0 |
0.0 |
GO:0035092 |
sperm chromatin condensation(GO:0035092) |
| 0.0 |
0.3 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.0 |
0.3 |
GO:0001553 |
luteinization(GO:0001553) |
| 0.0 |
0.3 |
GO:0043486 |
histone exchange(GO:0043486) |
| 0.0 |
0.1 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.0 |
0.3 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 |
0.0 |
GO:0034372 |
very-low-density lipoprotein particle remodeling(GO:0034372) |
| 0.0 |
0.3 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.0 |
0.1 |
GO:0033327 |
Leydig cell differentiation(GO:0033327) |
| 0.0 |
0.1 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.0 |
0.1 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.0 |
0.4 |
GO:0010591 |
regulation of lamellipodium assembly(GO:0010591) |
| 0.0 |
0.1 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.0 |
0.1 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.0 |
0.2 |
GO:0006044 |
N-acetylglucosamine metabolic process(GO:0006044) |
| 0.0 |
0.1 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 0.0 |
0.0 |
GO:0038095 |
Fc-epsilon receptor signaling pathway(GO:0038095) |
| 0.0 |
0.0 |
GO:0060160 |
negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 0.0 |
0.0 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
